Power Law company profile

Protagonist Therapeutics

Biotech & Life Sciences · Newark, United States · Founded 2006 · IPO 2016 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$5.78B

Market cap · Apr/2026

Revenue

$46M

Latest reported FY

Investors

10 investors on Protagonist Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

Starfish Ventures

Lilly Ventures

QIC BioVentures

Series B+ 7 investors entered at this stage

Foresite Capital

RA Capital Management

The University of Queensland

Canaan

Pharmstandard

Johnson & Johnson Development Corporation

Inbio Ventures

Global footprint

Where Protagonist Therapeutics has talent and traffic

Web traffic by country

9K monthly visits
across markets

🇺🇸 United States58.9%

🇮🇳 India15.6%

🇬🇧 United Kingdom10%

🇭🇰 Hong Kong5.6%

🇫🇷 France2.2%

Top 5 markets shown

Patent intelligence

$59M patent portfolio · 52 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$59M

1.0% of market cap · 34.6× smaller than top peer Ablynx ($2B)

52 active patent families

Where Protagonist Therapeutics innovates Molecular biologyPeptide inhibitorReceptorWhite blood cellInterleukin

Tracks the peer median across all five Patsnap quality dimensions.

Quality vs same-sector peers

Protagonist Therapeutics on the five Patsnap quality dimensions

Protagonist Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Protagonist Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Protagonist Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Protagonist Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo